Top stocks to watch on Democratic gains: First Solar, NextEra Energy, HCA Healthcare

Investing.com — The clearest longer-term beneficiaries of Democratic gains are clean energy, regulated power, and hospitals. The election changes policy risk more than earnings overnight.

Still guessing which stocks will beat the market? Our AI portfolio updates monthly and is outperforming the S&P 500 by 118%. See this month’s list »

1. Solar Support

First Solar benefits most directly from durable U.S. clean-energy incentives and domestic manufacturing support.

• Price: $202.00, up 8.66%, as of Nov 4, 2026, 10:35 AM EST.

• Revenue rose from $2.92B in 2021 to $5.22B in 2025.

• P/E: 10.7x, and fair-value upside is 9.1%, both as of Nov 4, 2026.

• The stock remains down 23.93% year to date, leaving room for policy-driven rerating.

The bear case is project delays, tariff changes, and weak solar demand. Still, this is the most direct policy beneficiary. Reuters coverage (Nov 2, 2026).

2. Grid Investment

NextEra Energy offers a steadier route into the clean-energy theme through regulated utility earnings and renewable development.

Unsure what to buy ahead of earnings? Our AI’s recent pre-earnings calls delivered gains of +77% to +118% after results dropped. See this month’s earnings picks »

• Price: $87.27, up 3.48%, as of Nov 4, 2026, 10:35 AM EST.

• Revenue increased from $17.07B in 2021 to $27.41B in 2025.

• Revenue growth was 9.6%, while EPS growth reached 76.7%, as of Sep 30, 2026.

• Its fair-value estimate shows 16.9% downside, as of Nov 4, 2026.

That valuation warning matters. The political tailwind is strong, but the stock already carries a premium. The bull case is accelerated grid spending; the bear case is higher financing costs and overvaluation.

3. Hospital Pricing Power

HCA Healthcare is the strongest healthcare candidate because hospital demand is less exposed to drug-price regulation than pharmaceutical companies.

• Price: $495.38, up 7.03%, as of Nov 4, 2026, 10:35 AM EST.

• Revenue climbed from $58.75B in 2021 to $75.60B in 2025.

• Revenue growth was 5.8%, EPS growth 17.1%, and P/E 15.3x, as of Sep 30, 2026.

• Fair-value upside was 4.6%, as of Nov 4, 2026.

The bear case is Medicaid reimbursement pressure and labor costs. The bull case is broader healthcare funding and resilient admissions. Democrats may scrutinize insurers, but hospitals can benefit from higher utilization and coverage.

Take

The ranking is First Solar for policy sensitivity, NextEra Energy for durability, and HCA Healthcare for operating resilience. Gridlock remains likely, so implementation—not election headlines—will decide the longer-term winners. Election-sector analysis (Nov 4, 2026).

Source: finance.yahoo.com — article syndicated from the publisher’s feed; all rights remain with the original publisher.